Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/11/17
End: 07/03/18
Due: 07/03/19
Phase: N/A
Priority: Normal
Start: 03/29/19
End: 04/19/21
Due: 04/19/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a | NCT03320265 | Athera Biotechnologies AB | user2@example.com | None | 2017-10-11 | 2018-07-03 | 2019-07-03 | - | - | 2025-07-14 |
| Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction | NCT03991143 | Athera Biotechnologies AB | user2@example.com | None | 2019-03-29 | 2021-04-19 | 2022-04-19 | - | - | 2025-07-14 |